Sign In
Buy ABBV
$227.23
+2.30 (+1.02%)
At Close: Jun 05, 2026
Wall Street Analysts And Options Market Suggest AbbVie Has Upside
04:48pm, Monday, 06'th Feb 2023
There is widespread concern about the impact of Humira biosimilars being available in the U.S. The consensus outlook is that ABBV's earnings will decline.
Is AbbVie A Buy Following The Share Price Slump?
07:30am, Monday, 06'th Feb 2023
AbbVie has seen its shares pull back in recent weeks. Humira has gone off patent in the US, but other assets are generating strong growth.
AbbVie Aims for New Drugs to Boost Sales as Competitors Target Humira
05:30am, Monday, 06'th Feb 2023
Drugmaker is turning to next-generation successors to Humira to replenish billions of dollars in sales that will be lost, and lifting a self-imposed $2 billion limit on the size of deals it would do t
AbbVie: The Dreaded Humira Cliff Is Here: Time To Sell?
05:00pm, Sunday, 05'th Feb 2023
The day has arrived: Biosimilars for the blockbuster drug Humira are now being sold in the US. AbbVie investors are rightfully apprehensive, although the company has prepared for this day for years.
These 2 dividend-stock ETFs are more like growth funds in disguise. Can either still work in your income portfolio?
01:32pm, Saturday, 04'th Feb 2023 MarketWatch
Quality-stock and dividend-focused strategies shined during the market declines of 2022. One such fund is also designed to perform well in all markets.
2 Stocks Down More Than 6% to Buy Right Now
01:30pm, Saturday, 04'th Feb 2023 The Motley Fool
These companies outperformed the market last year.
3 Unstoppable Dividend Stocks to Buy in February
12:45pm, Saturday, 04'th Feb 2023 The Motley Fool
All three belong to the elite group of stocks known as Dividend Kings.
2 Stocks Down More Than 6% to Buy Right Now
08:30am, Saturday, 04'th Feb 2023
These companies outperformed the market last year.
3 Unstoppable Dividend Stocks to Buy in February
07:45am, Saturday, 04'th Feb 2023
All three belong to the elite group of stocks known as Dividend Kings.
5 Best and Worst Performing Mega-Cap Stocks in January 2023
10:53pm, Friday, 03'rd Feb 2023
The stock market finished January on a positive note. This is a good sign for investors, who incurred huge losses last year.
AbbVie Q4 Preview: What's in Store?
10:31pm, Friday, 03'rd Feb 2023 Zacks Investment Research
AbbVie has put in a mixed earnings performance, exceeding bottom line estimates in five consecutive quarters but falling short of sales expectations in each instance.
AbbVie Q4 Preview: What's in Store?
06:49pm, Friday, 03'rd Feb 2023
AbbVie has put in a mixed earnings performance, exceeding bottom line estimates in five consecutive quarters but falling short of sales expectations in each instance.
If You Want Tons of Passive Income in the Future , Buy These 2 Stocks
03:07pm, Friday, 03'rd Feb 2023 The Motley Fool
Good cash flows come to those who pick intelligently and wait.
Investors Heavily Search AbbVie Inc. (ABBV): Here is What You Need to Know
02:00pm, Friday, 03'rd Feb 2023 Zacks Investment Research
Zacks.com users have recently been watching AbbVie (ABBV) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
2 Steady Stocks to Buy in a Recession
02:00pm, Friday, 03'rd Feb 2023 The Motley Fool
Both companies are performing better than the broader market over the past year.
